EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells

Ewelina Madej, Anna Lisek, Anna A Brożyna, Agnieszka Cierniak, Norbert Wronski, Milena Deptula, Anna Wardowska, Agnieszka Wolnicka-Glubisz

Journal of Cancer Research and Clinical Oncology · 24.04.2024 · 150 (4)

DOI: 10.1007/s00432-024-05732-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 24.04.2024. Verfasst von Ewelina Madej und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, …. Hauptthemen laut MEDLINE: Melanoma, Interleukin-6, Tumor Necrosis Factor-alpha, Interleukin-8. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The receptor-interacting protein kinase (RIPK4) has an oncogenic function in melanoma, regulates NF-κB and Wnt/β-catenin pathways, and is sensitive to the BRAF inhibitors: vemurafenib and dabrafenib which lead to its decreased level. As its role in melanoma remains not fully understood, we examined the effects of its downregulation on the transcriptomic profile of melanoma.

Methods

Applying RNA-seq, we revealed global alterations in the transcriptome of WM266.4 cells with RIPK4 silencing. Functional partners of RIPK4 were evaluated using STRING and GeneMANIA databases. Cells with transient knockdown (via siRNA) and stable knockout (via CRISPR/Cas9) of RIPK4 were stimulated with TNF-α. The expression levels of selected proteins were assessed using Western blot, ELISA, and qPCR.

Results

Global analysis of gene expression changes indicates a complex role for RIPK4 in regulating adhesion, migration, proliferation, and inflammatory processes in melanoma cells. Our study highlights potential functional partners of RIPK4 such as BIRC3, TNF-α receptors, and MAP2K6. Data from RIPK4 knockout cells suggest a putative role for RIPK4 in modulating TNF-α-induced production of IL-8 and IL-6 through two distinct signaling pathways—BIRC3/NF-κB and p38/MAPK. Furthermore, increased serum TNF-α levels and the correlation of RIPK4 with NF-κB were revealed in melanoma patients.

Conclusion

These data reveal a complex role for RIPK4 in regulating the immune signaling network in melanoma cells and suggest that this kinase may represent an alternative target for melanoma-targeted adjuvant therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaInterleukin-6Tumor Necrosis Factor-alphaInterleukin-8HumansCell Line, TumorProtein Serine-Threonine KinasesCell ProliferationGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BIRC3CytokinesMelanomaRIPK4RNA-seqTranscriptomep-38

Substanzen

Interleukin-6Tumor Necrosis Factor-alphaInterleukin-8RIPK4 protein, humanProtein Serine-Threonine KinasesIL6 protein, humanCXCL8 protein, human

Autor:innen und Institutionen

  • Department of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387, Kraków, Poland.
  • Department of Human Biology, Insitute of Biology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Lwowska1, 87-100, Toruń, Poland.
  • Department of Biochemistry, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland.
  • Doctoral School of Exact and Natural Sciences, Jagiellonian University, Kraków, Poland.
  • Laboratory of Tissue Engineering and Regenerative Medicine, Division of Embryology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
  • Department of Physiopathology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Madej, E., Lisek, A., Brożyna, A. A., Cierniak, A., Wronski, N., Deptula, M., Wardowska, A., & Wolnicka-Glubisz, A. (2024). The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells. Journal of Cancer Research and Clinical Oncology, 150(4). https://doi.org/10.1007/s00432-024-05732-3

Vancouver

Madej E, Lisek A, Brożyna AA, Cierniak A, Wronski N, Deptula M, et al. The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells. Journal of Cancer Research and Clinical Oncology. 2024;150(4). doi:10.1007/s00432-024-05732-3

BibTeX
@article{Madej2024,
  author = {Madej, Ewelina and Lisek, Anna and Brożyna, Anna A and Cierniak, Agnieszka and Wronski, Norbert and Deptula, Milena and Wardowska, Anna and Wolnicka-Glubisz, Agnieszka},
  title = {The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  volume = {150},
  number = {4},
  doi = {10.1007/s00432-024-05732-3}
}
Kostenlos starten →